Nebenwirkungen · HyQvia
HyQvia 100 mg/mL solution for infusion for subcutaneous use · Abschnitt 4.8 · PDF-Seite 12–13
HOS-126380 · Präparat HOS-096247
12 MedDRA Frequency Frequency System Organ Adverse drug reactions per patient per infusion Class (SOC) N=228 N=7,287 Migraine Common Uncommon Paraesthesia Common Uncommon Burning sensation Common Uncommon Tremor Common Rare Cerebrovascular accident Uncommon Rare and Ischaemic stroke Cardiac Sinus tachycardia and Common Uncommon disorders Tachycardia Hypertension and Blood Vascular Very Common Uncommon pressure increased disorders Hypotension Common Rare Respiratory, thoracic, and Dyspnoea Common Rare mediastinal disorders Nausea Very Common Common Abdominal pain, Abdominal pain lower, Abdominal pain Very Common Uncommon Gastrointestinal upper and Abdominal disorders tenderness Diarrhoea Very Common Uncommon Vomiting Very Common Uncommon Abdominal distension Common Uncommon Erythema Common Uncommon Pruritus Common Uncommon Skin and Rash, Rash erythematous, subcutaneous Rash macular, Rash maculo- Common Uncommon tissue disorders papular and Rash papular Urticaria Common Uncommon Hyperhidrosis Common Rare Myalgia Common Uncommon Arthralgia Very Common Uncommon Limb discomfort and Pain in Musculoskeletal Common Uncommon extremity and connective Back pain Common Uncommon tissue disorders Joint stiffness Uncommon Uncommon Musculoskeletal chest pain Common Uncommon Groin pain Common Rare Renal and urinary Haemosiderinuria Common Rare disorders
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-05-27T11:30:00Z · SHA-256 82c2d181906f7f26df4b044c3162c2753297176713b9df6564f85902166acac6 · Passage d4603729167a1e5d67813e879e398fe4d13747df64a737351a165e7bbd76ac17 · Zeichen 4107–6931 im Abschnitt